Researchers have successfully shown that a new genetic test can, with high sensitivity, determine which pancreatic cysts are most likely to be associated with an aggressive form of pancreatic cancer.
The successful results are a critical step toward a precision medicine approach to detecting and treating pancreatic cancer, which has one of the lowest survival rates of all cancers. Read more. . .